Efficacy and Safety of Janus Kinase-Inhibitors in Ulcerative Colitis
Benedetto Neri, Roberto Mancone, Mariasofia Fiorillo, Sara Concetta Schiavone, Stefano Migliozzi, Livia Biancone · 2024
Read Efficacy and Safety of Janus Kinase-Inhibitors in Ulcerative Colitis by Benedetto Neri, Roberto Mancone, Mariasofia Fiorillo, Sara Concetta Schiavone, Stefano Migliozzi, Livia Biancone (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11642564.txt.
Description
Six doctors in Italy review a class of drugs for ulcerative colitis in a 2024 paper. The drugs block Janus kinase, a signal path in immune cells, and they are taken by mouth. The authors searched two large databases for trials and real world studies of the three approved drugs.
The review sums up how well each drug brings on response and calm disease. It also covers healing of the gut wall and safety in daily use. The drugs act fast, which the authors count as a plus. Risks raised in early work include infections and clots, so the team stresses care in picking which patients should get them.
Catalog record
| CREATOR | Benedetto Neri, Roberto Mancone, Mariasofia Fiorillo, Sara Concetta Schiavone, Stefano Migliozzi, Livia Biancone |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |